1. Quantitative modeling predicts competitive advantages of a next generation anti‐NKG2A monoclonal antibody over monalizumab for the treatment of cancer. (13th February 2021) Authors: Spinosa, Phillip; Musial‐Siwek, Monika; Presler, Marc; Betts, Alison; Rosentrater, Emily; Villali, Janice; Wille, Lucia; Zhao, Yang; McCaughtry, Tom; Subramanian, Kalyanasundaram; Liu, Hanlan Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 10:Number 3(2021) Page Start: 220 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗